Latest news
Psychiatry Mid-Year Market Update 2026: Persistent Demand, Widening Valuation Gap, and Workforce/Regulatory Realities - Psychiatric TimesPsychiatric Times · Thu, 06 Aug 2026 18:15:39 GMTFDA Approves Oveporexton for Narcolepsy Type 1, First Drug to Treat Full Range of NT1 Symptoms - Psychiatric TimesPsychiatric Times · Wed, 05 Aug 2026 20:45:21 GMTBringing Wearable Data Into Psychiatric Care: Amae Health Partners With Google Health Enterprise to Improve Outcomes - Psychiatric TimesPsychiatric Times · Tue, 04 Aug 2026 14:14:19 GMTRemission Rates in the First 2 Weeks of Treatment - Psychiatric TimesPsychiatric Times · Mon, 03 Aug 2026 19:00:00 GMTCentanafadine in ADHD: Clinical Significance of the First Triple Reuptake Inhibitor for ADHD - Psychiatric TimesPsychiatric Times · Mon, 03 Aug 2026 18:23:02 GMTPostpartum Psychosis on Trial: What the Lindsay Clancy Case Can Teach Us - Psychiatric TimesPsychiatric Times · Mon, 03 Aug 2026 15:07:55 GMTThe State of Alzheimer Disease Care: An Update From Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP - Psychiatric TimesPsychiatric Times · Mon, 03 Aug 2026 14:07:55 GMTThe Explosion of Alzheimer's Drug Research - Psychiatric TimesPsychiatric Times · Fri, 31 Jul 2026 20:30:00 GMT